A novel protein degradation system in young‐onset Parkinson's disease: Mitophagy is a therapeutic target as a quality control for damaged mitochondria
Identifieur interne : 004427 ( Istex/Curation ); précédent : 004426; suivant : 004428A novel protein degradation system in young‐onset Parkinson's disease: Mitophagy is a therapeutic target as a quality control for damaged mitochondria
Auteurs : Taku Hatano [Japon]Source :
- Movement Disorders [ 0885-3185 ] ; 2011-04.
Url:
DOI: 10.1002/mds.23754
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: Pour aller vers cette notice dans l'étape Curation :004427
Links to Exploration step
ISTEX:044958F78FDD9E90C404601EA0FEECEE3E266274Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">A novel protein degradation system in young‐onset Parkinson's disease: Mitophagy is a therapeutic target as a quality control for damaged mitochondria</title>
<author><name sortKey="Hatano, Taku" sort="Hatano, Taku" uniqKey="Hatano T" first="Taku" last="Hatano">Taku Hatano</name>
<affiliation wicri:level="1"><mods:affiliation>Department of Neurology, Juntendo University School of Medicine Tokyo, Japan</mods:affiliation>
<country xml:lang="fr">Japon</country>
<wicri:regionArea>Department of Neurology, Juntendo University School of Medicine Tokyo</wicri:regionArea>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:044958F78FDD9E90C404601EA0FEECEE3E266274</idno>
<date when="2011" year="2011">2011</date>
<idno type="doi">10.1002/mds.23754</idno>
<idno type="url">https://api.istex.fr/document/044958F78FDD9E90C404601EA0FEECEE3E266274/fulltext/pdf</idno>
<idno type="wicri:Area/Istex/Corpus">004427</idno>
<idno type="wicri:Area/Istex/Curation">004427</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">A novel protein degradation system in young‐onset Parkinson's disease: Mitophagy is a therapeutic target as a quality control for damaged mitochondria</title>
<author><name sortKey="Hatano, Taku" sort="Hatano, Taku" uniqKey="Hatano T" first="Taku" last="Hatano">Taku Hatano</name>
<affiliation wicri:level="1"><mods:affiliation>Department of Neurology, Juntendo University School of Medicine Tokyo, Japan</mods:affiliation>
<country xml:lang="fr">Japon</country>
<wicri:regionArea>Department of Neurology, Juntendo University School of Medicine Tokyo</wicri:regionArea>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series><title level="j">Movement Disorders</title>
<title level="j" type="abbrev">Mov. Disord.</title>
<idno type="ISSN">0885-3185</idno>
<idno type="eISSN">1531-8257</idno>
<imprint><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher>
<pubPlace>Hoboken</pubPlace>
<date type="published" when="2011-04">2011-04</date>
<biblScope unit="vol">26</biblScope>
<biblScope unit="issue">5</biblScope>
<biblScope unit="page" from="773">773</biblScope>
<biblScope unit="page" to="773">773</biblScope>
</imprint>
<idno type="ISSN">0885-3185</idno>
</series>
<idno type="istex">044958F78FDD9E90C404601EA0FEECEE3E266274</idno>
<idno type="DOI">10.1002/mds.23754</idno>
<idno type="ArticleID">MDS23754</idno>
</biblStruct>
</sourceDesc>
<seriesStmt><idno type="ISSN">0885-3185</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass></textClass>
<langUsage><language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
</TEI>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Istex/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 004427 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Istex/Curation/biblio.hfd -nk 004427 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Santé |area= MovDisordV3 |flux= Istex |étape= Curation |type= RBID |clé= ISTEX:044958F78FDD9E90C404601EA0FEECEE3E266274 |texte= A novel protein degradation system in young‐onset Parkinson's disease: Mitophagy is a therapeutic target as a quality control for damaged mitochondria }}
![]() | This area was generated with Dilib version V0.6.23. | ![]() |